LA
CVS icon

Lynch & Associates’s CVS Health CVS Stock Holding History

Lynch & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.58M Buy
22,878
+2,996
+15% +$207K 0.32% 67
2025
Q1 		$1.35M Buy
19,882
+75
+0.4% +$5.08K 0.29% 72
2024
Q4 		$889K Sell
19,807
-6,088
-24% -$273K 0.19% 75
2024
Q3 		$1.63M Sell
25,895
-1,826
-7% -$115K 0.34% 65
2024
Q2 		$1.64M Sell
27,721
-1,605
-5% -$94.8K 0.37% 61
2024
Q1 		$2.34M Sell
29,326
-571
-2% -$45.5K 0.54% 52
2023
Q4 		$2.36M Sell
29,897
-1,059
-3% -$83.6K 0.57% 50
2023
Q3 		$2.16M Sell
30,956
-3,260
-10% -$228K 0.57% 48
2023
Q2 		$2.37M Sell
34,216
-7,248
-17% -$501K 0.61% 47
2023
Q1 		$3.08M Sell
41,464
-4,246
-9% -$316K 0.81% 42
2022
Q4 		$4.26M Sell
45,710
-575
-1% -$53.6K 1.11% 31
2022
Q3 		$4.41M Buy
46,285
+5,215
+13% +$497K 1.29% 28
2022
Q2 		$3.81M Buy
41,070
+384
+0.9% +$35.6K 1.04% 33
2022
Q1 		$4.12M Buy
40,686
+556
+1% +$56.3K 1% 35
2021
Q4 		$4.14M Buy
40,130
+4,003
+11% +$413K 0.98% 36
2021
Q3 		$3.07M Buy
36,127
+2,031
+6% +$172K 0.79% 41
2021
Q2 		$2.85M Buy
34,096
+9,922
+41% +$828K 0.73% 44
2021
Q1 		$1.82M Buy
24,174
+4,931
+26% +$371K 0.49% 52
2020
Q4 		$1.31M Buy
19,243
+1,892
+11% +$129K 0.36% 58
2020
Q3 		$1.01M Buy
17,351
+1,255
+8% +$73.3K 0.3% 61
2020
Q2 		$1.05M Buy
16,096
+5,230
+48% +$340K 0.34% 56
2020
Q1 		$645K Sell
10,866
-143
-1% -$8.49K 0.24% 65
2019
Q4 		$818K Buy
11,009
+317
+3% +$23.6K 0.24% 65
2019
Q3 		$674K Buy
10,692
+1,272
+14% +$80.2K 0.21% 67
2019
Q2 		$513K Buy
+9,420
New +$513K 0.17% 73